DataMeds AI (MEDS) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 36 63 sessions, July 22, 2026 to October 19, 2026
- Largest daily move
- +274.7% close of September 16, 2026
- 1-month change
- -29% closing prices, September 18, 2026 to October 19, 2026
Company Description
DataMeds AI (NASDAQ: MEDS) is classified in the medical distribution industry within the Healthcare sector and carries a market capitalization of $8.4M.
MEDS has declined 29.0% over the past month. The last closing price was $2.67.
For FY2025, DataMeds AI reported revenue of $23.3M with net income of -$101.3M and diluted earnings per share of -$1.43. The company operates at a net profit margin of -433.9%.
This page collects what Stock Titan holds for MEDS, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
DataMeds AI (MEDS) closed at $2.67 on October 19, 2026. Over the past month, the price has lost 29.0%.
MEDS Metrics & Rankings
Price returns through October 19, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
DataMeds AI has 10 recent news articles, with the latest published today. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include AI, crypto. View all MEDS news →
SEC Filings
DataMeds AI has filed 10 recent SEC filings, including 6 Form 8-K, 2 Form PRE 14C, 1 Form S-1/A, 1 Form 10-Q. The most recent filing was submitted on October 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MEDS SEC filings →
Financial Highlights
DataMeds AI generated $23.3M in revenue in FY2025, retaining a -27.5% gross margin, operating income reached -$93.7M (-401.7% operating margin), and net income was -$101.3M, reflecting a -433.9% net profit margin. Diluted earnings per share stood at -$1.43. The company generated -$10.9M in operating cash flow. The current ratio was 0.09, measuring current assets divided by current liabilities.
Upcoming Events
Cancer patient support
DataMeds AI has 1 upcoming scheduled event. The next event, "Cancer patient support", is scheduled for January 1, 2027 (in 72 days). Investors can track these dates to stay informed about potential catalysts that may affect the MEDS stock price.
Short Interest History
Short interest in DataMeds AI (MEDS) currently stands at 525.1 thousand shares, up 21.9% from the previous reporting period, representing 39.1% of the float. Since July 2026, short interest has increased by 414.6%.
Days to Cover History
Days to cover for DataMeds AI (MEDS) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
MEDS Company Profile & Sector Positioning
DataMeds AI (MEDS) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the NASDAQ.